FDA-approved treatments delivered to your door. Save up to 90% with The HRT ClubTM.
Indicated for the treatment of moderate to severe menopausal VMS and VVA, and for the prevention of postmenopausal osteoporosis.
Indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogen tablets and for use in secondary amenorrhea.
Indicated in a woman with a uterus for the treatment of moderate to severe vasomotor symptoms due to menopause.